Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
Stopped No clinical efficacy against SARS-CoV-2 recorded
Conditions
Interventions
- DRUG: UNIKINON (Chloroquine phosphate) 200mg tablets
Sponsor
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]